GGrantIndex
Sort

35,931 grants matching parkinsons

AGING AND DEMENTIA: CHOLINERGIC NEURON BIOCHEMISTRY

$375,750
Yeshiva University · R01 · FY2003 · MH

Function of glutamate delta-1 receptor

$375,736
Shashank Manohar Dravid · Creighton University · R01 · FY2020 · MH

Understanding the antagonistic role of proteostasis in Alzheimer disease and cancer.

$375,719
Alexander Richard Mendenhall · University Of Washington · R01 · FY2020 · CA

Factors mediating age-associated systemic inflammation

$375,680
Jyoti Sen · National Institute On Aging · ZIA · FY2016 · AG

The role of VAMP2 in alpha-synuclein function and pathology

$375,609
Jiajie Diao · University Of Cincinnati · R01 · FY2023 · NS

The role of VAMP2 in alpha-synuclein function and pathology

$375,609
Jiajie Diao · University Of Cincinnati · R01 · FY2022 · NS

Hyperpolarized 129-Xenon-based MRI Probes for Brain Injury

$375,595
Jeremy Phillip Celver · Kovogen · R43 · FY2010 · NS

Chemical and Molecular Tools for Modulating GPCR Function

$375,567
David E Olson · University Of California At Davis · R35 · FY2023 · GM

CRCNS: Modeling the role of auditory feedback in speech motor control

$375,557
John Francis Houde · University Of California, San Francisco · R01 · FY2020 · DC

Mechanisms Underlying Axonopathy in Hereditary Spastic Paraplegia

$375,430
Anjon Audhya · University Of Wisconsin-Madison · R01 · FY2022 · NS

Mechanisms Underlying Axonopathy in Hereditary Spastic Paraplegia

$375,430
Anjon Audhya · University Of Wisconsin-Madison · R01 · FY2025 · NS

Mechanisms Underlying Axonopathy in Hereditary Spastic Paraplegia

$375,430
Anjon Audhya · University Of Wisconsin-Madison · R01 · FY2023 · NS

A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)

$375,420
Charbel Moussa · Georgetown University · R01 · FY2020 · AG

Translational Foundation of Adenosine Antagonist Use for Dyskinesias

$375,419
Michael A Schwarzschild · Massachusetts General Hospital · R01 · FY2006 · NS

Function of glutamate delta-1 receptor

$375,390
Shashank Manohar Dravid · Creighton University · R01 · FY2019 · MH

Pan-Lipoxygenase Inhibitors for CNS Disease

$375,373
David R Schubert · Salk Institute For Biological Studies · R01 · FY2012 · AG

Pan-Lipoxygenase Inhibitors for CNS Disease

$375,373
David R Schubert · Salk Institute For Biological Studies · R01 · FY2014 · AG

Pan-Lipoxygenase Inhibitors for CNS Disease

$375,373
David R Schubert · Salk Institute For Biological Studies · R01 · FY2011 · AG

Multimodal Correlation of Imaging Markers and Neuropathogenesis of NeuroAIDS

$375,350
Jacopo Annese · University Of California, San Diego · R01 · FY2009 · MH

Cortical Control of Motor Learning

$375,331
Takaki Komiyama · University Of California, San Diego · R01 · FY2024 · NS

Structure of Prion Amyloids

$375,312
Reed B. Wickner · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK

Neurotoxicity of nanomaterials: evaluation of subcellular redox state

$375,301
Gary W Miller · Emory University · R01 · FY2008 · ES

Adhesion Signature-Based, Label-Free Isolation of Pluripotent Stem Cell Derived N

$375,214
Jamie Meredith Chilton · Aruna Biomedical, Inc. · R43 · FY2013 · NS

Spatial control of membrane traffic by septin GTPases

$375,185
Elias T Spiliotis · Drexel University · R35 · FY2022 · GM

Neuronal Control of Interactions Among Behaviors

$375,156
William B Kristan · University Of California, San Diego · R01 · FY2010 · MH